Evidence map›Paper›PMID 14999099›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice.

David A Goukassian, Elizabeth Helms, Harry van Steeg, Conny van Oostrom, Jag Bhawan, Barbara A Gilchrest

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Hormesis: Decoding Two Sides of the Same Coin.Pharmaceuticals (Basel, Switzerland) · 2015
    Review
  3. A bio-mimetic approach to DNA photoprotection.The Journal of investigative dermatology · 2014
    Article
  4. Article
  5. Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation.American journal of physiology. Endocrinology and metabolism · 2011
    Article
  6. Article
  7. Article
  8. Novel investigational drugs for basal cell carcinoma.Expert opinion on investigational drugs · 2010
    Review
  9. Mimetics of hormetic agents: stress-resistance triggers.Dose-response : a publication of International Hormesis Society · 2010
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A role for WRN in telomere-based DNA damage responses.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

David A GoukassianDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA. dgoukass@bu.edu
Elizabeth Helms
Harry van Steeg
Conny van Oostrom
Jag Bhawan
Barbara A Gilchrest
Boston University · USNational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UV-induced DNA damage gives rise to mutations and skin cancer. We have previously reported that treatment of skin cells in vitro with thymidine dinucleotide (pTT) activates p53 and increases the ability of cells to repair subsequent UV-induced DNA damage by enhancing endogenous DNA repair capacity. Here we show that topical pTT pretreatment enhances the rate of DNA photoproduct removal, decreases UV-induced mutations, and reduces photocarcinogenesis in UV-irradiated hairless WT repair-proficient and Xpc(+/-) heterozygous partially repair-deficient mice, both transgenic for the lacZ/pUR288 mutation-indicator gene. These data support the existence of inducible mammalian DNA damage responses that increase DNA repair capacity after DNA damage and hence reduce the impact of future exposures to environmental carcinogens. The ability of topically applied pTT to induce protective physiologic responses that normally result from DNA damage suggests a previously undescribed means of reducing skin cancer in high-risk individuals.

Indexed as

Administration, TopicalAnimalsAntimutagenic AgentsDNA RepairMiceMice, HairlessMutationNeoplasmsOligodeoxyribonucleotidesPyrimidine DimersSkin NeoplasmsTumor Suppressor Protein p53Ultraviolet RaysUp-RegulationAntimutagenic AgentsOligodeoxyribonucleotidesPyrimidine DimersTumor Suppressor Protein p53

Identifiers

PMID14999099
PMCPMC374347
OpenAlexW2138320589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.